Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030

1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.2.1 MARKETS COVERED 35 1.2.2 INCLUSIONS & EXCLUSIONS 36 1.2.3 YEARS CONSIDERED 37 1.3 CURRENCY 37 1.4 UNIT CONSIDERED 37 1.5 STAKEHOLDERS 38 1.6 SUMMARY OF CHANGES 38 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH APPROACH 40 2.1.1 SECONDARY DATA 40 2.1.1.1 Key data from secondary sources 42 2.1.2 PRIMARY DATA 42 2.1.2.1 Key data from primary sources 44 2.1.2.2 Key industry insights 45 2.2 MARKET SIZE ESTIMATION 47 2.2.1 TOP-DOWN APPROACH 52 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53 2.4 MARKET SHARE ESTIMATION 53 2.5 STUDY ASSUMPTIONS 54 2.6 RISK ASSESSMENT 54 2.7 RESEARCH LIMITATIONS 55 2.7.1 METHODOLOGY-RELATED LIMITATIONS 55 2.7.2 SCOPE-RELATED LIMITATIONS 55 3 EXECUTIVE SUMMARY 56 4 PREMIUM INSIGHTS 63 4.1 CATHETERS MARKET OVERVIEW 63 4.2 NORTH AMERICA: CATHETERS MARKET OVERVIEW 64 4.3 CATHETERS MARKET: REGIONAL MIX 65 4.4 CATHETERS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 65 4.5 CATHETERS MARKET: DEVELOPING VS. DEVELOPED MARKETS 66   5 MARKET OVERVIEW 67 5.1 INTRODUCTION 67 5.2 MARKET DYNAMICS 67 5.2.1 DRIVERS 68 5.2.1.1 Rising geriatric population 68 5.2.1.2 Increasing prevalence of chronic diseases 68 5.2.1.3 Increased awareness and treatment of urinary incontinence 69 5.2.1.4 Rising demand for minimally invasive surgeries 69 5.2.2 RESTRAINTS 70 5.2.2.1 Product recalls and failures 70 5.2.2.2 Presence of substitute medical devices 70 5.2.3 OPPORTUNITIES 71 5.2.3.1 Growing demand in emerging markets 71 5.2.3.2 Technological advancements and product innovation 71 5.2.4 CHALLENGES 72 5.2.4.1 Integration complexity with existing production lines 72 5.3 TECHNOLOGY ANALYSIS 73 5.3.1 KEY TECHNOLOGIES 73 5.3.1.1 Antimicrobial-coated catheters 73 5.3.1.2 Drug-eluting catheters 73 5.3.2 COMPLEMENTARY TECHNOLOGIES 73 5.3.2.1 Hydrophilic coatings for catheters 73 5.3.2.2 Ultrasound-guided insertion systems 74 5.3.3 ADJACENT TECHNOLOGIES 74 5.3.3.1 Minimally invasive surgical devices 74 5.4 PORTER’S FIVE FORCES ANALYSIS 75 5.4.1 INTENSITY OF COMPETITIVE RIVALRY 76 5.4.2 BARGAINING POWER OF BUYERS 76 5.4.3 BARGAINING POWER OF SUPPLIERS 76 5.4.4 THREAT OF SUBSTITUTES 76 5.4.5 THREAT OF NEW ENTRANTS 77 5.5 REGULATORY LANDSCAPE 77 5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 5.5.2 REGULATORY FRAMEWORK 79 5.5.2.1 North America 79 5.5.2.1.1 US 79 5.5.2.1.2 Canada 81 5.5.2.2 Europe 81 5.5.2.3 Asia Pacific 81 5.5.2.3.1 China 81 5.5.2.3.2 Japan 81 5.5.2.3.3 India 81 5.5.2.4 Latin America 82 5.5.2.4.1 Brazil 82 5.5.2.4.2 Mexico 82 5.5.2.5 Middle East 82 5.5.2.6 Africa 83 5.6 PATENT ANALYSIS 83 5.6.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR CATHETERS MARKET, JANUARY 2015–DECEMBER 2025 83 5.6.2 LIST OF MAJOR PATENTS, 2023–2024 85 5.7 TRADE ANALYSIS 86 5.7.1 IMPORT DATA FOR HS CODE 901839, 2020–2024 86 5.7.2 EXPORT DATA FOR HS CODE 901839, 2020–2024 87 5.8 REIMBURSEMENT SCENARIO 87 5.9 KEY CONFERENCES & EVENTS, 2025–2026 89 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 90 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 90 5.10.2 KEY BUYING CRITERIA 91 5.11 PRICING ANALYSIS 92 5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE, 2022–2024 92 5.11.2 AVERAGE SELLING PRICE TREND OF CATHETERS, BY REGION, 2022–2024 93 5.12 VALUE CHAIN ANALYSIS 94 5.13 ECOSYSTEM ANALYSIS 95 5.14 IMPACT OF AI/GEN AI ON CATHETERS MARKET 96 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 97 5.16 INVESTMENT & FUNDING SCENARIO 98 5.17 CATHETERS MARKET: IMPACT OF 2025 US TARIFF 98 5.17.1 INTRODUCTION 98 5.17.2 KEY TARIFF RATES 99 5.17.3 PRICE IMPACT ANALYSIS 99 5.17.4 IMPACT ON COUNTRY/REGION 100 5.17.4.1 North America 100 5.17.4.2 Europe 100 5.17.4.3 Asia Pacific 100 5.17.5 IMPACT ON END USERS 101 5.17.5.1 Hospitals 101 5.17.5.2 Ambulatory surgical centers 101 5.17.5.3 Long-term care facilities 101 5.17.5.4 Diagnostic imaging centers 101 5.17.5.5 Outpatient clinics 101 5.17.5.6 Other end users 101 6 CATHETERS MARKET, BY TYPE 102 6.1 INTRODUCTION 103 6.2 CARDIOVASCULAR CATHETERS 103 6.2.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES AND GROWING INTERVENTIONAL PROCEDURES TO FUEL DEMAND 103 6.2.2 ELECTROPHYSIOLOGY CATHETERS 105 6.2.2.1 Increasing prevalence of atrial fibrillation and expansion of electrophysiology labs to drive segment 105 6.2.3 ANGIOGRAPHY CATHETERS 107 6.2.3.1 Growing use of minimally invasive diagnostics and better imaging outcomes to propel growth 107 6.2.4 CORONARY BALLOON CATHETERS 108 6.2.4.1 Rapid growth in percutaneous coronary interventions and technological innovation to support growth 108 6.2.5 IVUS/OCT CATHETERS 110 6.2.5.1 Integration of intravascular imaging into PCI and clinical guidelines to drive uptake 110 6.2.6 GUIDING CATHETERS 111 6.2.6.1 Versatility in access and support during complex interventions to boost demand 111 6.2.7 OTHER CARDIOVASCULAR CATHETERS 112 6.3 INTRAVENOUS CATHETERS 114 6.3.1 INCREASING USE IN LONG-TERM THERAPIES AND HOSPITAL-ACQUIRED INFECTION PREVENTION EFFORTS TO DRIVE GROWTH 114 6.3.2 GLOBAL VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 114 6.3.3 CENTRAL VENOUS CATHETERS 116 6.3.3.1 Rising use in intensive and emergency care, along with multi-lumen design advancements, to drive demand 116 6.3.3.2 Peripherally inserted central catheters 117 6.3.3.2.1 Preference for long-term, outpatient IV therapy and reduced complication rates to drive use 117 6.3.3.3 Non-tunneled central venous catheters 119 6.3.3.3.1 Immediate access in emergency and ICU settings supports continued use 119 6.3.3.4 Skin-tunneled central venous catheters 120 6.3.3.4.1 Low infection risk and suitability for long-term therapies drive adoption 120 6.3.3.5 Implantable ports 122 6.3.3.5.1 Rise in cancer prevalence and demand for discreet, low-maintenance access devices drive use 122 6.3.4 PERIPHERAL INTRAVENOUS CATHETERS 123 6.3.4.1 High frequency of use and cost-effectiveness drive widespread adoption 123   6.3.5 MIDLINE PERIPHERAL CATHETERS 125 6.3.5.1 Rising preference in infection-prone patients and long-duration therapies to fuel market growth 125 6.4 UROLOGICAL CATHETERS 127 6.4.1 AGING POPULATION AND RISE IN RENAL AND UROLOGICAL DISORDERS TO DRIVE DEMAND 127 6.4.2 URINARY CATHETERS 129 6.4.2.1 Rising geriatric population and increased incidence of urinary incontinence - key drivers of growth 129 6.4.2.2 Indwelling catheters 130 6.4.2.2.1 Hospital-acquired urinary retention cases and long-term catheterization needs to drive demand 130 6.4.2.3 Intermittent catheters 131 6.4.2.3.1 Rising preference for self-catheterization and reduced infection risk accelerates adoption 131 6.4.2.4 External catheters 133 6.4.2.4.1 Growing use of non-invasive options in female and bedridden patients to fuel demand 133 6.4.3 DIALYSIS CATHETERS 135 6.4.3.1 Rising prevalence of end-stage renal disease and need for immediate vascular access to drive use 135 6.4.3.2 Peritoneal dialysis catheters 136 6.4.3.2.1 Preference for home-based renal therapy to support segment growth 136 6.4.3.3 Hemodialysis catheters 137 6.4.3.3.1 Increasing prevalence of end-stage renal disease and urgency for rapid vascular access to drive demand 137 6.5 SPECIALTY CATHETERS 139 6.5.1 DIVERSE CLINICAL UTILITY AND ADVANCEMENTS IN MINIMALLY INVASIVE MONITORING TO SUPPORT GROWTH 139 6.5.2 PRESSURE & HEMODYNAMIC CATHETERS 140 6.5.2.1 Precision in critical care and expanding cardiac monitoring – key drivers 140 6.5.3 TEMPERATURE MONITORING CATHETERS 142 6.5.3.1 Segment to gain traction due to need for precise core temperature control in critical illness 142 6.5.4 INTRAUTERINE INSEMINATION CATHETERS 143 6.5.4.1 Rising use of assisted reproduction and favorable clinical outcomes support growth of segment 143 6.5.5 OTHER SPECIALTY CATHETERS 145 6.6 NEUROVASCULAR CATHETERS 146 6.6.1 INCREASING STROKE BURDEN AND SHIFT TOWARD ENDOVASCULAR THERAPY TO ACCELERATE DEMAND 146   7 CATHETERS MARKET, BY INDICATION 148 7.1 INTRODUCTION 149 7.2 CARDIAC DISEASES 149 7.2.1 GROWING CARDIOVASCULAR DISEASE BURDEN TO DRIVE DOMINANCE OF SEGMENT 149 7.3 NEUROVASCULAR CONDITIONS 150 7.3.1 INCREASING STROKE INCIDENCE AND ADVANCED NEURO-INTERVENTION TECHNIQUES TO FUEL SEGMENT 150 7.4 URINARY CONDITIONS 152 7.4.1 RISING CASES OF URINARY INCONTINENCE AND UROLOGICAL DISORDERS TO DRIVE DEMAND 152 7.5 VASCULAR DISEASES 153 7.5.1 PREVALENCE OF PERIPHERAL ARTERY DISEASE AND DEEP VEIN THROMBOSIS AIDS GROWTH OF SEGMENT 153 7.6 IV MEDICATION DELIVERY & FLUID MANAGEMENT 155 7.6.1 GROWING USE OF LONG-TERM IV THERAPY IN CHRONIC CONDITIONS TO SUPPORT EXPANSION OF SEGMENT 155 7.7 KIDNEY DISEASES 156 7.7.1 HIGH GLOBAL BURDEN OF END-STAGE RENAL DISEASE TO ACCELERATE GROWTH 156 7.8 BLOOD TRANSFUSION 158 7.8.1 INCREASE IN SURGICAL VOLUME AND CRITICAL CARE NEEDS TO DRIVE DEMAND 158 7.9 OTHER INDICATIONS 159 8 CATHETERS MARKET, BY END USER 161 8.1 INTRODUCTION 162 8.2 HOSPITALS 162 8.2.1 RAPID EXPANSION OF HOSPITAL CAPACITY AND INFRASTRUCTURE TO DRIVE MARKET 162 8.3 AMBULATORY SURGICAL CENTERS 163 8.3.1 SURGE IN OUTPATIENT PROCEDURES AND REGULATORY SUPPORT TO SPUR GROWTH 163 8.4 LONG-TERM CARE FACILITIES 164 8.4.1 AGING POPULATION AND ASSISTED LIVING DEMAND INCREASED CATHETER USE 164 8.5 DIAGNOSTIC IMAGING CENTERS 166 8.5.1 HIGH VOLUME OF IMAGING PROCEDURES BOOSTS CATHETER DEMAND 166 8.6 OUTPATIENT CLINICS 167 8.6.1 RISING OUTPATIENT VISIT VOLUMES AND PROCEDURAL SHIFT INCREASE CATHETER USE 167 8.7 OTHER END USERS 168   9 CATHETERS MARKET, BY REGION 169 9.1 INTRODUCTION 170 9.2 NORTH AMERICA 171 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171 9.2.2 NORTH AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023--2030 (THOUSAND UNITS) 174 9.2.3 US 177 9.2.3.1 Rising chronic disease burden spurs innovation demand in catheter use 177 9.2.4 CANADA 182 9.2.4.1 Aging population and rising hypertension & urinary conditions lift catheter demand 182 9.3 EUROPE 187 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 187 9.3.2 EUROPE: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 189 9.3.3 GERMANY 192 9.3.3.1 Aging population and high PCI volume to drive catheter usage 192 9.3.4 UK 196 9.3.4.1 High prevalence of long‑term urinary catheter use maintained by community nursing demand 196 9.3.5 FRANCE 200 9.3.5.1 Widespread use of intermittent urinary catheters to support second-largest share 200 9.3.6 SPAIN 204 9.3.6.1 Rising UTI burden in nursing homes boosts urinary catheter demand 204 9.3.7 ITALY 208 9.3.7.1 Recent heightened CAUTI risk in ICUs underpins demand for safer urinary catheters 208 9.3.8 REST OF EUROPE 212 9.4 ASIA PACIFIC 216 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 216 9.4.2 ASIA PACIFIC VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 218 9.4.3 JAPAN 222 9.4.3.1 Aging population and rising cardiovascular care needs to boost demand for catheters 222 9.4.4 CHINA 226 9.4.4.1 High cardiovascular disease burden and expanding care access to drive demand 226 9.4.5 INDIA 230 9.4.5.1 Set to be fastest‑growing market with escalating CVD incidence 230 9.4.6 AUSTRALIA 234 9.4.6.1 High cardiovascular disease burden and strong government support to drive growth 234 9.4.7 SOUTH KOREA 239 9.4.7.1 Rising arrhythmia treatments and expanding interventional cardiology infrastructure bolster catheter demand 239 9.4.8 REST OF ASIA PACIFIC 243 9.5 LATIN AMERICA 248 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 248 9.5.2 LATIN AMERICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 250 9.5.3 BRAZIL 253 9.5.3.1 Robust public healthcare infrastructure and high cardiovascular procedure volume drive dominance 253 9.5.4 MEXICO 258 9.5.4.1 High diabetes and cardiovascular disease prevalence spurs catheter demand 258 9.5.5 REST OF LATIN AMERICA 262 9.6 MIDDLE EAST & AFRICA 267 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 267 9.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF INTRAVENOUS CATHETER TYPES, 2023–2030 (THOUSAND UNITS) 269 9.6.3 GCC COUNTRIES 273 9.6.3.1 Market uplift through strategic healthcare investments and rising procedure volumes 273 9.6.3.2 Kingdom of Saudi Arabia (KSA) 277 9.6.3.2.1 Market gains strength from healthcare transformation and NCD burden 277 9.6.3.3 United Arab Emirates (UAE) 282 9.6.3.3.1 Market growth anchored in advanced hospital infrastructure and medical tourism 282 9.6.3.4 Other GCC Countries 286 9.6.4 REST OF MIDDLE EAST & AFRICA 290 10 COMPETITIVE LANDSCAPE 294 10.1 OVERVIEW 294 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 294 10.3 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022–2024) 296 10.4 MARKET SHARE ANALYSIS 297 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 298 10.5.1 STARS 298 10.5.2 EMERGING LEADERS 299 10.5.3 PERVASIVE PLAYERS 299 10.5.4 PARTICIPANTS 299 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 300 10.5.5.1 Company footprint 300 10.5.5.2 Region footprint 301 10.5.5.3 Type footprint 302 10.5.5.4 Indication footprint 303 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 304 10.6.1 PROGRESSIVE COMPANIES 304 10.6.2 DYNAMIC COMPANIES 304 10.6.3 STARTING BLOCKS 304 10.6.4 RESPONSIVE COMPANIES 304 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 306 10.6.5.1 Detailed list of key startups/SMEs 306 10.6.5.2 Competitive benchmarking of key emerging players/startups 307 10.7 BRAND/PRODUCT COMPARISON 308 10.8 R&D EXPENDITURE OF KEY PLAYERS 308 10.9 COMPANY VALUATION & FINANCIAL METRICS 309 10.9.1 COMPANY VALUATION 309 10.9.2 FINANCIAL METRICS 309 10.10 COMPETITIVE SCENARIO 310 10.10.1 PRODUCT APPROVALS/LAUNCHES 310 10.10.2 DEALS 311 10.10.3 EXPANSIONS 312 10.10.4 OTHER DEVELOPMENTS 313 11 COMPANY PROFILES 314 11.1 KEY PLAYERS 314 11.1.1 BOSTON SCIENTIFIC CORPORATION 314 11.1.1.1 Business overview 314 11.1.1.2 Products offered 315 11.1.1.3 Recent developments 318 11.1.1.3.1 Product launches & approvals 318 11.1.1.3.2 Deals 319 11.1.1.4 MnM view 319 11.1.1.4.1 Right to win 319 11.1.1.4.2 Strategic choices 319 11.1.1.4.3 Weaknesses and competitive threats 320 11.1.2 MEDTRONIC PLC 321 11.1.2.1 Business overview 321 11.1.2.2 Products offered 322 11.1.2.3 Recent developments 324 11.1.2.3.1 Product launches & approvals 324 11.1.2.3.2 Deals 324 11.1.2.4 MnM view 325 11.1.2.4.1 Right to win 325 11.1.2.4.2 Strategic choices 325 11.1.2.4.3 Weaknesses and competitive threats 325 11.1.3 B. BRAUN SE 326 11.1.3.1 Business overview 326 11.1.3.2 Products offered 327 11.1.3.3 Recent developments 329 11.1.3.3.1 Deals 329 11.1.3.3.2 Expansions 329 11.1.3.4 MnM view 329 11.1.3.4.1 Right to win 329 11.1.3.4.2 Strategic choices 330 11.1.3.4.3 Weaknesses and competitive threats 330 11.1.4 BECTON, DICKINSON AND COMPANY 331 11.1.4.1 Business overview 331 11.1.4.2 Products offered 332 11.1.4.3 Recent developments 334 11.1.4.3.1 Product launches & approvals 334 11.1.4.3.2 Deals 334 11.1.4.3.3 Expansions 334 11.1.4.4 MnM view 335 11.1.4.4.1 Right to win 335 11.1.4.4.2 Strategic choices 335 11.1.4.4.3 Weaknesses and competitive threats 335 11.1.5 STRYKER CORPORATION 336 11.1.5.1 Business overview 336 11.1.5.2 Products offered 337 11.1.5.3 Recent developments 338 11.1.5.3.1 Product launches & approvals 338 11.1.5.3.2 Deals 338 11.1.5.4 MnM view 339 11.1.5.4.1 Right to win 339 11.1.5.4.2 Strategic choices 339 11.1.5.4.3 Weaknesses and competitive threats 339 11.1.6 ABBOTT LABORATORIES 340 11.1.6.1 Business overview 340 11.1.6.2 Products offered 341 11.1.6.3 Recent developments 342 11.1.6.3.1 Product launches & approvals 342 11.1.6.3.2 Deals 343 11.1.6.3.3 Other developments 343   11.1.7 TERUMO CORPORATION 344 11.1.7.1 Business overview 344 11.1.7.2 Products offered 345 11.1.7.3 Recent developments 346 11.1.7.3.1 Product launches & approvals 346 11.1.7.3.2 Deals 347 11.1.7.3.3 Expansions 347 11.1.8 COLOPLAST A/S 348 11.1.8.1 Business overview 348 11.1.8.2 Products offered 349 11.1.8.3 Recent developments 351 11.1.8.3.1 Product launches & approvals 351 11.1.8.3.2 Expansions 351 11.1.9 CONVATEC GROUP PLC 352 11.1.9.1 Business overview 352 11.1.9.2 Products offered 354 11.1.9.3 Recent developments 354 11.1.9.3.1 Product launches & approvals 354 11.1.10 MERIT MEDICAL SYSTEMS, INC. 355 11.1.10.1 Business overview 355 11.1.10.2 Products offered 356 11.1.10.3 Recent developments 358 11.1.10.3.1 Product launches & approvals 358 11.1.10.3.2 Deals 358 11.1.11 JOHNSON & JOHNSON 359 11.1.11.1 Business overview 359 11.1.11.2 Products offered 360 11.1.11.3 Recent developments 361 11.1.11.3.1 Product launches & approvals 361 11.1.11.3.2 Deals 363 11.1.12 COOK 364 11.1.12.1 Business overview 364 11.1.12.2 Products offered 364 11.1.12.3 Recent developments 366 11.1.12.3.1 Product launches & approvals 366 11.1.12.3.2 Deals 366 11.1.13 EDWARDS LIFESCIENCES CORPORATION 367 11.1.13.1 Business overview 367 11.1.13.2 Products offered 368   11.1.14 NIPRO CORPORATION 369 11.1.14.1 Business overview 369 11.1.14.2 Products offered 370 11.1.14.3 Recent developments 371 11.1.14.3.1 Expansions 371 11.1.15 TELEFLEX INCORPORATED 372 11.1.15.1 Business overview 372 11.1.15.2 Products offered 373 11.1.15.3 Recent developments 375 11.1.15.3.1 Product launches & approvals 375 11.1.15.3.2 Deals 375 11.1.16 CARDINAL HEALTH, INC. 376 11.1.16.1 Business overview 376 11.1.16.2 Products offered 377 11.1.16.3 Recent developments 378 11.1.16.3.1 Expansions 378 11.1.17 HOLLISTER INCORPORATED 379 11.1.17.1 Business overview 379 11.1.17.2 Products offered 379 11.1.17.3 Recent developments 380 11.1.17.3.1 Expansions 380 11.1.18 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 381 11.1.18.1 Business overview 381 11.1.18.2 Products offered 382 11.1.19 KONINKLIJKE PHILIPS N.V. 384 11.1.19.1 Business overview 384 11.1.19.2 Products offered 385 11.1.19.3 Recent developments 386 11.1.19.3.1 Expansions 386 11.1.20 MICROPORT SCIENTIFIC CORPORATION 387 11.1.20.1 Business overview 387 11.1.20.2 Products offered 389 11.1.20.3 Recent developments 389 11.1.20.3.1 Product launches & approvals 389 11.2 OTHER PLAYERS 391 11.2.1 AMECATH 391 11.2.2 SIS MEDICAL AG 392 11.2.3 ANGIPLAST PRIVATE LIMITED 393 11.2.4 RELISYS MEDICAL DEVICES LIMITED 394 11.2.5 CAGENT VASCULAR 395 11.2.6 BIOTRONIK 396 11.2.7 ADVIN HEALTH CARE 398 11.2.8 ALVIMEDICA 399 11.2.9 INGENION MEDICAL LIMITED 400 11.2.10 SUMMA THERAPEUTICS, LLC 401 12 APPENDIX 402 12.1 DISCUSSION GUIDE 402 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 411 12.3 CUSTOMIZATION OPTIONS 413 12.3.1 PRODUCT ANALYSIS 413 12.3.2 GEOGRAPHIC ANALYSIS 413 12.3.3 COMPANY INFORMATION 413 12.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 413 12.3.5 COUNTRY-LEVEL VOLUME ANALYSIS 413 12.3.6 PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 413 12.3.7 ANY CONSULTS/CUSTOM STUDIES AS PER CLIENT REQUIREMENTS 413 12.4 RELATED REPORTS 414 12.5 AUTHOR DETAILS 415

TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 37 TABLE 2 CATHETERS MARKET: STUDY ASSUMPTION ANALYSIS 54 TABLE 3 CATHETERS MARKET: RISK ASSESSMENT ANALYSIS 54 TABLE 4 CATHETERS MARKET: PORTER’S FIVE FORCES 75 TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION 80 TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 80 TABLE 12 CATHETERS MARKET: KEY PATENTS, JANUARY 2023–DECEMBER 2024 85 TABLE 13 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION) 86 TABLE 14 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2020–2024 (USD MILLION) 87 TABLE 15 CATHETERS MARKET: KEY CONFERENCES & EVENTS, JULY 2025−JUNE 2026 89 TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 90 TABLE 17 KEY BUYING CRITERIA FOR CATHETERS 91 TABLE 18 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY CATHETER TYPE, 2022–2024 (USD) 92 TABLE 19 AVERAGE SELLING PRICE OF CATHETERS, BY REGION, 2022–2024 (USD) 93 TABLE 20 CATHETERS MARKET: IMPACT OF AI/GEN AI 96 TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 99 TABLE 22 CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 103 TABLE 23 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 24 CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 105 TABLE 25 ELECTROPHYSIOLOGY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 106 TABLE 26 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 108 TABLE 27 CORONARY BALLOON CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 109 TABLE 28 IVUS/OCT CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 111 TABLE 29 GUIDING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 112 TABLE 30 OTHER CARDIOVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 113 TABLE 31 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 114 TABLE 32 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 115 TABLE 33 INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 115 TABLE 34 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 116 TABLE 35 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 117 TABLE 36 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 118 TABLE 37 NON-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 120 TABLE 38 SKIN-TUNNELED CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 121 TABLE 39 IMPLANTABLE PORTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 123 TABLE 40 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 124 TABLE 41 MIDLINE PERIPHERAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 126 TABLE 42 UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 43 UROLOGICAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 128 TABLE 44 URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 45 URINARY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 130 TABLE 46 INDWELLING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 131 TABLE 47 INTERMITTENT CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 132 TABLE 48 EXTERNAL CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 134 TABLE 49 DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135 TABLE 50 DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 136 TABLE 51 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 137 TABLE 52 HEMODIALYSIS CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 138 TABLE 53 SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 54 SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 140 TABLE 55 PRESSURE & HEMODYNAMIC CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 141 TABLE 56 TEMPERATURE MONITORING CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 143 TABLE 57 INTRAUTERINE INSEMINATION CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 144 TABLE 58 OTHER SPECIALTY CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 145 TABLE 59 NEUROVASCULAR CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 147 TABLE 60 CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 149 TABLE 61 CARDIAC DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 150 TABLE 62 NEUROVASCULAR CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 151 TABLE 63 URINARY CONDITIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 153 TABLE 64 VASCULAR DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 154 TABLE 65 IV MEDICATION DELIVERY & FLUID MANAGEMENT: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 156 TABLE 66 KIDNEY DISEASES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 157 TABLE 67 BLOOD TRANSFUSION: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 159 TABLE 68 OTHER INDICATIONS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 160 TABLE 69 CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 70 HOSPITALS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 163 TABLE 71 AMBULATORY SURGICAL CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 164 TABLE 72 LONG-TERM CARE FACILITIES: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 165 TABLE 73 DIAGNOSTIC IMAGING CENTERS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 166 TABLE 74 OUTPATIENT CLINICS: CATHETERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 167 TABLE 75 OTHER END USERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 168 TABLE 76 CATHETERS MARKET, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 77 NORTH AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 78 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 79 NORTH AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 80 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS) 174 TABLE 81 NORTH AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 82 NORTH AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 83 NORTH AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 84 NORTH AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 85 NORTH AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 86 NORTH AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 87 NORTH AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 176 TABLE 88 NORTH AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 177 TABLE 89 US: KEY MACROINDICATORS 178 TABLE 90 US: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 91 US: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 92 US: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 93 US: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 94 US: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 95 US: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 96 US: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 97 US: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 98 US: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 181 TABLE 99 US: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 100 CANADA: KEY MACROINDICATORS 183 TABLE 101 CANADA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 102 CANADA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 103 CANADA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 104 CANADA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 105 CANADA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 106 CANADA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 107 CANADA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 108 CANADA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 109 CANADA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 186 TABLE 110 CANADA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 186 TABLE 111 EUROPE: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 112 EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 113 EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 114 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS) 189 TABLE 115 EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 116 EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 117 EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 118 EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 119 EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 120 EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 121 EUROPE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 191 TABLE 122 EUROPE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 123 GERMANY: KEY MACROINDICATORS 192 TABLE 124 GERMANY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 125 GERMANY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 126 GERMANY: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 127 GERMANY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 128 GERMANY: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 129 GERMANY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 130 GERMANY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 131 GERMANY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 132 GERMANY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 195 TABLE 133 GERMANY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 134 UK: KEY MACROINDICATORS 196 TABLE 135 UK: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 136 UK: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 137 UK: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 138 UK: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 139 UK: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 140 UK: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 141 UK: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 142 UK: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 143 UK: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 199 TABLE 144 UK: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 145 FRANCE: KEY MACROINDICATORS 200 TABLE 146 FRANCE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 147 FRANCE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 148 FRANCE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 149 FRANCE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 150 FRANCE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 151 FRANCE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 152 FRANCE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 153 FRANCE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 154 FRANCE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 203 TABLE 155 FRANCE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 156 SPAIN: KEY MACROINDICATORS 204 TABLE 157 SPAIN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 158 SPAIN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 159 SPAIN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 160 SPAIN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 161 SPAIN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 162 SPAIN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 163 SPAIN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 164 SPAIN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 165 SPAIN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 207 TABLE 166 SPAIN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 167 ITALY: KEY MACROINDICATORS 208 TABLE 168 ITALY: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 169 ITALY: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 170 ITALY: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 171 ITALY: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 172 ITALY: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 173 ITALY: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 174 ITALY: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 175 ITALY: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 176 ITALY: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 211 TABLE 177 ITALY: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 178 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 179 REST OF EUROPE: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 180 REST OF EUROPE: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 181 REST OF EUROPE: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 182 REST OF EUROPE: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 183 REST OF EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 184 REST OF EUROPE: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 185 REST OF EUROPE: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 186 REST OF EUROPE: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 215 TABLE 187 REST OF EUROPE: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 216 TABLE 188 ASIA PACIFIC: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 189 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 190 ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 191 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS) 218 TABLE 192 ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 193 ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 194 ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 195 ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 196 ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 197 ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 198 ASIA PACIFIC: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 221 TABLE 199 ASIA PACIFIC: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 200 JAPAN: KEY MACROINDICATORS 222 TABLE 201 JAPAN: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 202 JAPAN: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 203 JAPAN: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 204 JAPAN: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 205 JAPAN: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 206 JAPAN: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 207 JAPAN: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 208 JAPAN: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 209 JAPAN: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 225 TABLE 210 JAPAN: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 211 CHINA: KEY MACROINDICATORS 226 TABLE 212 CHINA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 213 CHINA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 214 CHINA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 215 CHINA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 216 CHINA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 217 CHINA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 218 CHINA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 219 CHINA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 220 CHINA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 229 TABLE 221 CHINA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 222 INDIA: KEY MACROINDICATORS 230 TABLE 223 INDIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 224 INDIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 225 INDIA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 226 INDIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 227 INDIA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 228 INDIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 229 INDIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 230 INDIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 231 INDIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 233 TABLE 232 INDIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 233 AUSTRALIA: KEY MACROINDICATORS 235 TABLE 234 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 235 AUSTRALIA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 236 AUSTRALIA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 237 AUSTRALIA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 238 AUSTRALIA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 239 AUSTRALIA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 240 AUSTRALIA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 241 AUSTRALIA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 242 AUSTRALIA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 238 TABLE 243 AUSTRALIA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 244 SOUTH KOREA: KEY MACROINDICATORS 239 TABLE 245 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 246 SOUTH KOREA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 247 SOUTH KOREA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 248 SOUTH KOREA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 249 SOUTH KOREA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 250 SOUTH KOREA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 251 SOUTH KOREA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 252 SOUTH KOREA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 253 SOUTH KOREA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 242 TABLE 254 SOUTH KOREA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 255 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 256 REST OF ASIA PACIFIC: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 257 REST OF ASIA PACIFIC: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 258 REST OF ASIA PACIFIC: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 259 REST OF ASIA PACIFIC: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 260 REST OF ASIA PACIFIC: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 261 REST OF ASIA PACIFIC: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 262 REST OF ASIA PACIFIC: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 263 REST OF ASIA PACIFIC: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 247 TABLE 264 REST OF ASIA PACIFIC: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 247 TABLE 265 LATIN AMERICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 266 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 267 LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 268 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS) 250 TABLE 269 LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 270 LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 271 LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 272 LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 273 LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 274 LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 275 LATIN AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 252 TABLE 276 LATIN AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 277 BRAZIL: KEY MACROINDICATORS 253 TABLE 278 BRAZIL: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 279 BRAZIL: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 280 BRAZIL: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 281 BRAZIL: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 282 BRAZIL: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 283 BRAZIL: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 284 BRAZIL: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 285 BRAZIL: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 286 BRAZIL: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 257 TABLE 287 BRAZIL: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 288 MEXICO: KEY MACROINDICATORS 258 TABLE 289 MEXICO: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 290 MEXICO: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 291 MEXICO: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 292 MEXICO: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 293 MEXICO: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 294 MEXICO: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 295 MEXICO: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 296 MEXICO: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 297 MEXICO: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 261 TABLE 298 MEXICO: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 299 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 300 REST OF LATIN AMERICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 301 REST OF LATIN AMERICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 302 REST OF LATIN AMERICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 303 REST OF LATIN AMERICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 304 REST OF LATIN AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 305 REST OF LATIN AMERICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 306 REST OF LATIN AMERICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 307 REST OF LATIN AMERICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 266 TABLE 308 REST OF LATIN AMERICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 266 TABLE 309 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 310 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 311 MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 312 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, (2023–2030) (THOUSAND UNITS) 269 TABLE 313 MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 314 MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 315 MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 316 MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 317 MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 318 MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 319 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 272 TABLE 320 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 272 TABLE 321 GCC COUNTRIES: CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 273 TABLE 322 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 323 GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 324 GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 325 GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 326 GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 327 GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 328 GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 329 GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 330 GCC COUNTRIES: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 276 TABLE 331 GCC COUNTRIES: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 332 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 333 KINGDOM OF SAUDI ARABIA (KSA): CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 334 KINGDOM OF SAUDI ARABIA (KSA): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 335 KINGDOM OF SAUDI ARABIA (KSA): CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 336 KINGDOM OF SAUDI ARABIA (KSA): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 337 KINGDOM OF SAUDI ARABIA (KSA): URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 338 KINGDOM OF SAUDI ARABIA (KSA): DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 339 KINGDOM OF SAUDI ARABIA (KSA): SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 340 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 281 TABLE 341 KINGDOM OF SAUDI ARABIA (KSA): CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 342 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 343 UNITED ARAB EMIRATES (UAE): CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 344 UNITED ARAB EMIRATES (UAE): INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 345 UNITED ARAB EMIRATES (UAE): CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 346 UNITED ARAB EMIRATES (UAE): UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 347 UNITED ARAB EMIRATES (UAE): URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 348 UNITED ARAB EMIRATES (UAE): DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 349 UNITED ARAB EMIRATES (UAE): SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 350 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 285 TABLE 351 UNITED ARAB EMIRATES (UAE): CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 352 OTHER GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 353 OTHER GCC COUNTRIES: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 354 OTHER GCC COUNTRIES: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 355 OTHER GCC COUNTRIES: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 356 OTHER GCC COUNTRIES: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 357 OTHER GCC COUNTRIES: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 358 OTHER GCC COUNTRIES: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 359 OTHER GCC COUNTRIES: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 360 OTHER GCC COUNTRIES: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 289 TABLE 361 OTHER GCC COUNTRIES: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 362 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 363 REST OF MIDDLE EAST & AFRICA: CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 364 REST OF MIDDLE EAST & AFRICA: INTRAVENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 365 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 366 REST OF MIDDLE EAST & AFRICA: UROLOGICAL CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 367 REST OF MIDDLE EAST & AFRICA: URINARY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 368 REST OF MIDDLE EAST & AFRICA: DIALYSIS CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 369 REST OF MIDDLE EAST & AFRICA: SPECIALTY CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 370 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY INDICATION, 2023–2030 (USD MILLION) 293 TABLE 371 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY END USER, 2023–2030 (USD MILLION) 293 TABLE 372 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATHETERS MARKET 294 TABLE 373 CATHETERS MARKET: DEGREE OF COMPETITION 298 TABLE 374 CATHETERS MARKET: REGION FOOTPRINT 301 TABLE 375 CATHETERS MARKET: TYPE FOOTPRINT 302 TABLE 376 CATHETERS MARKET: INDICATION FOOTPRINT 303 TABLE 377 LIST OF KEY STARTUPS/SMES 306 TABLE 378 COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 307 TABLE 379 CATHETERS MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2022–JULY 2025 310 TABLE 380 CATHETERS MARKET: DEALS, JANUARY 2022–JULY 2025 311 TABLE 381 CATHETERS MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 312 TABLE 382 CATHETERS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 313 TABLE 383 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 314 TABLE 384 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 315 TABLE 385 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 318 TABLE 386 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 319 TABLE 387 MEDTRONIC PLC: BUSINESS OVERVIEW 321 TABLE 388 MEDTRONIC PLC: PRODUCTS OFFERED 322 TABLE 389 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 324 TABLE 390 MEDTRONIC PLC: DEALS, JANUARY 2022–JULY 2025 324 TABLE 391 B. BRAUN SE: BUSINESS OVERVIEW 326 TABLE 392 B. BRAUN SE: PRODUCTS OFFERED 327 TABLE 393 B. BRAUN SE: DEALS, JANUARY 2022–JULY 2025 329 TABLE 394 B. BRAUN SE: EXPANSIONS, JANUARY 2022–JULY 2025 329 TABLE 395 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 331 TABLE 396 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 332 TABLE 397 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 334 TABLE 398 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2022–JULY 2025 334 TABLE 399 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2022–JULY 2025 334 TABLE 400 STRYKER CORPORATION: BUSINESS OVERVIEW 336 TABLE 401 STRYKER CORPORATION: PRODUCTS OFFERED 337 TABLE 402 STRYKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 338 TABLE 403 STRYKER CORPORATION: DEALS, JANUARY 2022–JULY 2025 338 TABLE 404 ABBOTT LABORATORIES: BUSINESS OVERVIEW 340 TABLE 405 ABBOTT LABORATORIES: PRODUCTS OFFERED 341 TABLE 406 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 342 TABLE 407 ABBOTT LABORATORIES: DEALS, JANUARY 2022–JULY 2025 343 TABLE 408 ABBOTT LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 343 TABLE 409 TERUMO CORPORATION: BUSINESS OVERVIEW 344 TABLE 410 TERUMO CORPORATION: PRODUCTS OFFERED 345 TABLE 411 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 346 TABLE 412 TERUMO CORPORATION: DEALS, JANUARY 2022–JULY 2025 347 TABLE 413 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 347 TABLE 414 COLOPLAST A/S: BUSINESS OVERVIEW 348 TABLE 415 COLOPLAST A/S: PRODUCTS OFFERED 349 TABLE 416 COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 351 TABLE 417 COLOPLAST A/S: EXPANSIONS, JANUARY 2022–JULY 2025 351 TABLE 418 CONVATEC GROUP PLC: BUSINESS OVERVIEW 352 TABLE 419 CONVATEC GROUP PLC: PRODUCTS OFFERED 354 TABLE 420 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 354 TABLE 421 MERIT MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW 355 TABLE 422 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 356 TABLE 423 MERIT MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 358 TABLE 424 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2022–JULY 2025 358 TABLE 425 JOHNSON & JOHNSON: BUSINESS OVERVIEW 359 TABLE 426 JOHNSON & JOHNSON: PRODUCTS OFFERED 360 TABLE 427 JOHNSON & JOHNSON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 361 TABLE 428 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025 363 TABLE 429 COOK: BUSINESS OVERVIEW 364 TABLE 430 COOK: PRODUCTS OFFERED 364 TABLE 431 COOK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 366 TABLE 432 COOK: DEALS, JANUARY 2022–JULY 2025 366 TABLE 433 EDWARDS LIFESCIENCES CORPORATION: BUSINESS OVERVIEW 367 TABLE 434 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 368 TABLE 435 NIPRO CORPORATION: BUSINESS OVERVIEW 369 TABLE 436 NIPRO CORPORATION: PRODUCTS OFFERED 370 TABLE 437 NIPRO CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 371 TABLE 438 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 372 TABLE 439 TELEFLEX INCORPORATED: PRODUCTS OFFERED 373 TABLE 440 TELEFLEX INCORPORATED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 375 TABLE 441 TELEFLEX INCORPORATED: DEALS, JANUARY 2022–JULY 2025 375 TABLE 442 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 376 TABLE 443 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 377 TABLE 444 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2022–JULY 2025 378 TABLE 445 HOLLISTER INCORPORATED: BUSINESS OVERVIEW 379 TABLE 446 HOLLISTER INCORPORATED: PRODUCTS OFFERED 379 TABLE 447 HOLLISTER INCORPORATED: EXPANSIONS, JANUARY 2022–JULY 2025 380 TABLE 448 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW 381 TABLE 449 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS OFFERED 382 TABLE 450 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 384 TABLE 451 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 385 TABLE 452 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–JULY 2025 386 TABLE 453 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 387 TABLE 454 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 389 TABLE 455 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JULY 2025 389 FIGURE 1 CATHETERS MARKET: MARKETS & REGIONS COVERED 35 FIGURE 2 RESEARCH DESIGN 40 FIGURE 3 PRIMARY SOURCES 43 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 45 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 46 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 46 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 47 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 48 FIGURE 9 SUPPLY-SIDE ANALYSIS: CATHETERS MARKET (2024) 49 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030) 50 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51 FIGURE 12 DATA TRIANGULATION METHODOLOGY 53 FIGURE 13 CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 56 FIGURE 14 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57 FIGURE 15 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 57 FIGURE 16 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 58 FIGURE 17 UROLOGICAL CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 58 FIGURE 18 URINARY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 59 FIGURE 19 DIALYSIS CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 59 FIGURE 20 SPECIALTY CATHETERS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 60 FIGURE 21 CATHETERS MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION) 60 FIGURE 22 CATHETERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 61 FIGURE 23 GEOGRAPHIC SNAPSHOT: CATHETERS MARKET 62 FIGURE 24 INCREASING PREVALENCE OF CHRONIC DISEASES DRIVES GROWTH OF CATHETERS MARKET 63 FIGURE 25 CARDIOVASCULAR CATHETERS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2024 64 FIGURE 26 ASIA PACIFIC TO GROW FASTEST IN MARKET THROUGHOUT FORECAST PERIOD 65 FIGURE 27 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 65 FIGURE 28 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 66 FIGURE 29 CATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 FIGURE 30 CATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 75 FIGURE 31 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–DECEMBER 2024) 84 FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR CATHETER PATENTS (JANUARY 2015–DECEMBER 2024) 85 FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 90 FIGURE 34 KEY BUYING CRITERIA FOR CATHETERS 91 FIGURE 35 CATHETERS MARKET: VALUE CHAIN ANALYSIS 95 FIGURE 36 CATHETERS MARKET: ECOSYSTEM ANALYSIS 96 FIGURE 37 CATHETERS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 97 FIGURE 38 CATHETERS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 98 FIGURE 39 CATHETERS MARKET: REGIONAL GROWTH OPPORTUNITIES 170 FIGURE 40 NORTH AMERICA: CATHETERS MARKET SNAPSHOT 172 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN CATHETERS MARKET (2022−2024) 296 FIGURE 42 CATHETERS MARKET SHARE ANALYSIS OF KEY PLAYERS (2024) 297 FIGURE 43 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 299 FIGURE 44 CATHETERS MARKET: COMPANY FOOTPRINT 300 FIGURE 45 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 305 FIGURE 46 BRAND/PRODUCT COMPARATIVE ANALYSIS 308 FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN CATHETERS MARKET, 2022−2024 308 FIGURE 48 EV/EBITDA OF KEY VENDORS 309 FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 309 FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 315 FIGURE 51 MEDTRONIC PLC: COMPANY SNAPSHOT (2024) 322 FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2024) 327 FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 332 FIGURE 54 STRYKER CORPORATION: COMPANY SNAPSHOT (2024) 337 FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 341 FIGURE 56 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 345 FIGURE 57 COLOPLAST A/S: COMPANY SNAPSHOT (2024) 349 FIGURE 58 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 353 FIGURE 59 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2024) 356 FIGURE 60 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 360 FIGURE 61 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024) 368 FIGURE 62 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 370 FIGURE 63 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 373 FIGURE 64 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024) 377 FIGURE 65 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024) 382 FIGURE 66 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 385 FIGURE 67 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 388